Evidence map›Paper›PMID 33573645›Full record

ArticleBMC medical informatics and decision making2021

Performance evaluation of case definitions of type 1 diabetes for health insurance claims data in Japan.

Tasuku Okui, Chinatsu Nojiri, Shinichiro Kimura, Kentaro Abe, Sayaka Maeno, Masae Minami, Yasutaka Maeda, Naoko Tajima, Tomoyuki Kawamura, Naoki Nakashima

Open access · goldAbstract read
In one paragraph

Article in BMC medical informatics and decision making, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Tasuku OkuiMedical Information Center, Kyushu University Hospital, Maidashi 3-1-1 Higashi-ku, Fukuoka City, Fukuoka Prefecture, 812-8582, Japan. task10300@gmail.com.
Chinatsu NojiriMedical Information Center, Kyushu University Hospital, Maidashi 3-1-1 Higashi-ku, Fukuoka City, Fukuoka Prefecture, 812-8582, Japan.
Shinichiro KimuraDepartment of Molecular Medicine and Metabolism, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.
Kentaro AbeNational Hospital Organization Kokura Medical Center, Fukuoka, Japan.
Sayaka MaenoSasaki Diabetes Clinic, Fukuoka, Japan.
Masae MinamiClinic Masae Minami, Fukuoka, Japan.
Yasutaka MaedaClinic Masae Minami, Fukuoka, Japan.
Naoko TajimaJikei University School of Medicine, Tokyo, Japan.
Tomoyuki KawamuraDepartmentof Pediatrics, Osaka City University, Osaka, Japan.
Naoki NakashimaMedical Information Center, Kyushu University Hospital, Maidashi 3-1-1 Higashi-ku, Fukuoka City, Fukuoka Prefecture, 812-8582, Japan.
Kyushu University Hospital · JPJikei University School of Medicine · JPNagoya University · JPNational Hospital Organization · JPOsaka City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNo case definition of Type 1 diabetes (T1D) for the claims data has been proposed in Japan yet. This study aimed to evaluate the performance of candidate case definitions for T1D using Electronic health care records (EHR) and claims data in a University Hospital in Japan.

methodsThe EHR and claims data for all the visiting patients in a University Hospital were used. As the candidate case definitions for claims data, we constructed 11 definitions by combinations of International Statistical Classification of Diseases and Related Health Problems, Tenth Revision. (ICD 10) code of T1D, the claims code of insulin needles for T1D patients, basal insulin, and syringe pump for continuous subcutaneous insulin infusion (CSII). We constructed a predictive model for T1D patients using disease names, medical practices, and medications as explanatory variables. The predictive model was applied to patients of test group (validation data), and performances of candidate case definitions were evaluated.

resultsAs a result of performance evaluation, the sensitivity of the confirmed disease name of T1D was 32.9 (95% CI: 28.4, 37.2), and positive predictive value (PPV) was 33.3 (95% CI: 38.0, 38.4). By using the case definition of both the confirmed diagnosis of T1D and either of the claims code of the two insulin treatment methods (i.e., syringe pump for CSII and insulin needles), PPV improved to 90.2 (95% CI: 85.2, 94.4).

conclusionsWe have established a case definition with high PPV, and the case definition can be used for precisely detecting T1D patients from claims data in Japan.

Indexed as

Diabetes Mellitus, Type 1HumansInsulinInsurance, HealthInternational Classification of DiseasesJapanInsulinMachine learningPredictive modelType 1 diabetesValidation study

Identifiers

PMID33573645
PMCPMC7879626
OpenAlexW3126837476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.